nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN3B—testis—muscle cancer	0.0206	0.0918	CbGeAlD
Acamprosate—GRM5—head—muscle cancer	0.0134	0.0599	CbGeAlD
Acamprosate—GRM5—testis—muscle cancer	0.013	0.0579	CbGeAlD
Acamprosate—GRIN2D—tendon—muscle cancer	0.0111	0.0495	CbGeAlD
Acamprosate—SLC36A1—renal system—muscle cancer	0.0105	0.0469	CbGeAlD
Acamprosate—GRIN2C—head—muscle cancer	0.0102	0.0457	CbGeAlD
Acamprosate—GRIN2C—testis—muscle cancer	0.00988	0.0441	CbGeAlD
Acamprosate—GRIN2D—head—muscle cancer	0.00951	0.0425	CbGeAlD
Acamprosate—GRIN2D—testis—muscle cancer	0.00918	0.041	CbGeAlD
Acamprosate—GRIN3A—head—muscle cancer	0.00894	0.0399	CbGeAlD
Acamprosate—GRIN3A—testis—muscle cancer	0.00863	0.0386	CbGeAlD
Acamprosate—GRIN1—head—muscle cancer	0.00847	0.0378	CbGeAlD
Acamprosate—GRIN2A—tendon—muscle cancer	0.00824	0.0368	CbGeAlD
Acamprosate—SLC36A1—tendon—muscle cancer	0.00819	0.0366	CbGeAlD
Acamprosate—GRIN2B—head—muscle cancer	0.00808	0.0361	CbGeAlD
Acamprosate—SLC36A1—bone marrow—muscle cancer	0.00793	0.0354	CbGeAlD
Acamprosate—GRIN2A—vagina—muscle cancer	0.00765	0.0342	CbGeAlD
Acamprosate—SLC36A1—vagina—muscle cancer	0.0076	0.0339	CbGeAlD
Acamprosate—GRIN2A—head—muscle cancer	0.00706	0.0316	CbGeAlD
Acamprosate—SLC36A1—head—muscle cancer	0.00702	0.0314	CbGeAlD
Acamprosate—GRIN2A—testis—muscle cancer	0.00682	0.0305	CbGeAlD
Acamprosate—SLC36A1—testis—muscle cancer	0.00678	0.0303	CbGeAlD
Acamprosate—GABRG2—head—muscle cancer	0.00445	0.0199	CbGeAlD
Acamprosate—GABRA1—head—muscle cancer	0.00393	0.0176	CbGeAlD
Acamprosate—GABRB3—head—muscle cancer	0.00342	0.0153	CbGeAlD
Acamprosate—GABRB3—testis—muscle cancer	0.0033	0.0147	CbGeAlD
Acamprosate—Anaemia—Etoposide—muscle cancer	0.00179	0.00231	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00179	0.00231	CcSEcCtD
Acamprosate—Liver function test abnormal—Methotrexate—muscle cancer	0.00178	0.0023	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00178	0.0023	CcSEcCtD
Acamprosate—Increased appetite—Doxorubicin—muscle cancer	0.00178	0.00229	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00177	0.00228	CcSEcCtD
Acamprosate—Insomnia—Vincristine—muscle cancer	0.00177	0.00228	CcSEcCtD
Acamprosate—Paraesthesia—Vincristine—muscle cancer	0.00176	0.00226	CcSEcCtD
Acamprosate—Malaise—Etoposide—muscle cancer	0.00175	0.00226	CcSEcCtD
Acamprosate—Dermatitis bullous—Doxorubicin—muscle cancer	0.00175	0.00225	CcSEcCtD
Acamprosate—Breast disorder—Methotrexate—muscle cancer	0.00174	0.00225	CcSEcCtD
Acamprosate—Vertigo—Etoposide—muscle cancer	0.00174	0.00225	CcSEcCtD
Acamprosate—Leukopenia—Etoposide—muscle cancer	0.00174	0.00224	CcSEcCtD
Acamprosate—Abdominal pain—Dactinomycin—muscle cancer	0.00173	0.00223	CcSEcCtD
Acamprosate—Body temperature increased—Dactinomycin—muscle cancer	0.00173	0.00223	CcSEcCtD
Acamprosate—Cardiac failure—Doxorubicin—muscle cancer	0.00171	0.00221	CcSEcCtD
Acamprosate—Loss of consciousness—Etoposide—muscle cancer	0.00171	0.0022	CcSEcCtD
Acamprosate—Decreased appetite—Vincristine—muscle cancer	0.0017	0.00219	CcSEcCtD
Acamprosate—Cough—Etoposide—muscle cancer	0.00169	0.00218	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Vincristine—muscle cancer	0.00169	0.00218	CcSEcCtD
Acamprosate—Convulsion—Etoposide—muscle cancer	0.00168	0.00217	CcSEcCtD
Acamprosate—Hyponatraemia—Doxorubicin—muscle cancer	0.00168	0.00216	CcSEcCtD
Acamprosate—Hypertension—Etoposide—muscle cancer	0.00168	0.00216	CcSEcCtD
Acamprosate—Pain—Vincristine—muscle cancer	0.00167	0.00215	CcSEcCtD
Acamprosate—Constipation—Vincristine—muscle cancer	0.00167	0.00215	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00167	0.00215	CcSEcCtD
Acamprosate—Diplopia—Doxorubicin—muscle cancer	0.00167	0.00215	CcSEcCtD
Acamprosate—Asthma—Methotrexate—muscle cancer	0.00167	0.00215	CcSEcCtD
Acamprosate—Chest pain—Etoposide—muscle cancer	0.00165	0.00213	CcSEcCtD
Acamprosate—Eosinophilia—Methotrexate—muscle cancer	0.00165	0.00213	CcSEcCtD
Acamprosate—Migraine—Doxorubicin—muscle cancer	0.00165	0.00212	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00164	0.00211	CcSEcCtD
Acamprosate—Pancreatitis—Methotrexate—muscle cancer	0.00164	0.00211	CcSEcCtD
Acamprosate—Discomfort—Etoposide—muscle cancer	0.00163	0.0021	CcSEcCtD
Acamprosate—Face oedema—Doxorubicin—muscle cancer	0.00161	0.00208	CcSEcCtD
Acamprosate—Hypersensitivity—Dactinomycin—muscle cancer	0.00161	0.00208	CcSEcCtD
Acamprosate—Gastrointestinal pain—Vincristine—muscle cancer	0.0016	0.00206	CcSEcCtD
Acamprosate—Confusional state—Etoposide—muscle cancer	0.0016	0.00206	CcSEcCtD
Acamprosate—Anaphylactic shock—Etoposide—muscle cancer	0.00158	0.00204	CcSEcCtD
Acamprosate—Infection—Etoposide—muscle cancer	0.00157	0.00203	CcSEcCtD
Acamprosate—Asthenia—Dactinomycin—muscle cancer	0.00157	0.00202	CcSEcCtD
Acamprosate—Blood creatinine increased—Doxorubicin—muscle cancer	0.00157	0.00202	CcSEcCtD
Acamprosate—Thrombocytopenia—Etoposide—muscle cancer	0.00155	0.002	CcSEcCtD
Acamprosate—Tachycardia—Etoposide—muscle cancer	0.00155	0.00199	CcSEcCtD
Acamprosate—Abdominal pain—Vincristine—muscle cancer	0.00155	0.00199	CcSEcCtD
Acamprosate—Body temperature increased—Vincristine—muscle cancer	0.00155	0.00199	CcSEcCtD
Acamprosate—Liver function test abnormal—Doxorubicin—muscle cancer	0.00154	0.00199	CcSEcCtD
Acamprosate—Skin disorder—Etoposide—muscle cancer	0.00154	0.00198	CcSEcCtD
Acamprosate—Erectile dysfunction—Methotrexate—muscle cancer	0.00154	0.00198	CcSEcCtD
Acamprosate—Dry skin—Doxorubicin—muscle cancer	0.00153	0.00197	CcSEcCtD
Acamprosate—Hyperhidrosis—Etoposide—muscle cancer	0.00153	0.00197	CcSEcCtD
Acamprosate—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00153	0.00197	CcSEcCtD
Acamprosate—Photosensitivity reaction—Methotrexate—muscle cancer	0.00152	0.00196	CcSEcCtD
Acamprosate—Breast disorder—Doxorubicin—muscle cancer	0.00151	0.00195	CcSEcCtD
Acamprosate—Anorexia—Etoposide—muscle cancer	0.00151	0.00195	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00151	0.00194	CcSEcCtD
Acamprosate—Diarrhoea—Dactinomycin—muscle cancer	0.0015	0.00193	CcSEcCtD
Acamprosate—Pneumonia—Methotrexate—muscle cancer	0.0015	0.00193	CcSEcCtD
Acamprosate—Depression—Methotrexate—muscle cancer	0.00148	0.00191	CcSEcCtD
Acamprosate—Hypotension—Etoposide—muscle cancer	0.00148	0.00191	CcSEcCtD
Acamprosate—Gastritis—Doxorubicin—muscle cancer	0.00148	0.00191	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00147	0.0019	CcSEcCtD
Acamprosate—Abdominal distension—Doxorubicin—muscle cancer	0.00145	0.00187	CcSEcCtD
Acamprosate—Stomatitis—Methotrexate—muscle cancer	0.00145	0.00187	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—muscle cancer	0.00144	0.00186	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—muscle cancer	0.00144	0.00186	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—muscle cancer	0.00144	0.00186	CcSEcCtD
Acamprosate—Hypersensitivity—Vincristine—muscle cancer	0.00144	0.00186	CcSEcCtD
Acamprosate—Eosinophilia—Doxorubicin—muscle cancer	0.00143	0.00184	CcSEcCtD
Acamprosate—Sweating—Methotrexate—muscle cancer	0.00143	0.00184	CcSEcCtD
Acamprosate—Paraesthesia—Etoposide—muscle cancer	0.00142	0.00183	CcSEcCtD
Acamprosate—Haematuria—Methotrexate—muscle cancer	0.00142	0.00183	CcSEcCtD
Acamprosate—Pancreatitis—Doxorubicin—muscle cancer	0.00142	0.00183	CcSEcCtD
Acamprosate—Dyspnoea—Etoposide—muscle cancer	0.00141	0.00182	CcSEcCtD
Acamprosate—Somnolence—Etoposide—muscle cancer	0.00141	0.00181	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—muscle cancer	0.00141	0.00181	CcSEcCtD
Acamprosate—Epistaxis—Methotrexate—muscle cancer	0.0014	0.00181	CcSEcCtD
Acamprosate—Asthenia—Vincristine—muscle cancer	0.0014	0.00181	CcSEcCtD
Acamprosate—Vomiting—Dactinomycin—muscle cancer	0.00139	0.00179	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—muscle cancer	0.00139	0.00179	CcSEcCtD
Acamprosate—Rash—Dactinomycin—muscle cancer	0.00138	0.00178	CcSEcCtD
Acamprosate—Decreased appetite—Etoposide—muscle cancer	0.00138	0.00177	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00137	0.00176	CcSEcCtD
Acamprosate—Pain—Etoposide—muscle cancer	0.00135	0.00175	CcSEcCtD
Acamprosate—Constipation—Etoposide—muscle cancer	0.00135	0.00175	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—muscle cancer	0.00134	0.00173	CcSEcCtD
Acamprosate—Diarrhoea—Vincristine—muscle cancer	0.00134	0.00172	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—muscle cancer	0.00134	0.00172	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—muscle cancer	0.00134	0.00172	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—muscle cancer	0.00133	0.00172	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—muscle cancer	0.00133	0.00171	CcSEcCtD
Acamprosate—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00132	0.0017	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—muscle cancer	0.00132	0.00169	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—muscle cancer	0.00131	0.00168	CcSEcCtD
Acamprosate—Feeling abnormal—Etoposide—muscle cancer	0.00131	0.00168	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—muscle cancer	0.0013	0.00168	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—muscle cancer	0.0013	0.00168	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—muscle cancer	0.0013	0.00167	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—muscle cancer	0.0013	0.00167	CcSEcCtD
Acamprosate—Dizziness—Vincristine—muscle cancer	0.00129	0.00167	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—muscle cancer	0.00129	0.00166	CcSEcCtD
Acamprosate—Urticaria—Etoposide—muscle cancer	0.00126	0.00162	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—muscle cancer	0.00126	0.00162	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—muscle cancer	0.00125	0.00161	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—muscle cancer	0.00125	0.00161	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—muscle cancer	0.00125	0.00161	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—muscle cancer	0.00125	0.0016	CcSEcCtD
Acamprosate—Vomiting—Vincristine—muscle cancer	0.00124	0.0016	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—muscle cancer	0.00124	0.00159	CcSEcCtD
Acamprosate—Rash—Vincristine—muscle cancer	0.00123	0.00159	CcSEcCtD
Acamprosate—Dermatitis—Vincristine—muscle cancer	0.00123	0.00159	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—muscle cancer	0.00123	0.00158	CcSEcCtD
Acamprosate—Headache—Vincristine—muscle cancer	0.00123	0.00158	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—muscle cancer	0.00122	0.00157	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—muscle cancer	0.00121	0.00155	CcSEcCtD
Acamprosate—Chills—Methotrexate—muscle cancer	0.0012	0.00154	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—muscle cancer	0.00118	0.00152	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—muscle cancer	0.00117	0.00151	CcSEcCtD
Acamprosate—Hypersensitivity—Etoposide—muscle cancer	0.00117	0.0015	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—muscle cancer	0.00116	0.0015	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—muscle cancer	0.00116	0.0015	CcSEcCtD
Acamprosate—Nausea—Vincristine—muscle cancer	0.00116	0.0015	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—muscle cancer	0.00116	0.00149	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—muscle cancer	0.00116	0.00149	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—muscle cancer	0.00116	0.00149	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—muscle cancer	0.00115	0.00148	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—muscle cancer	0.00115	0.00148	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—muscle cancer	0.00114	0.00147	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—muscle cancer	0.00114	0.00147	CcSEcCtD
Acamprosate—Asthenia—Etoposide—muscle cancer	0.00114	0.00146	CcSEcCtD
Acamprosate—Back pain—Methotrexate—muscle cancer	0.00112	0.00145	CcSEcCtD
Acamprosate—Pruritus—Etoposide—muscle cancer	0.00112	0.00144	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—muscle cancer	0.00111	0.00144	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—muscle cancer	0.00108	0.0014	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—muscle cancer	0.00108	0.00139	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—muscle cancer	0.00108	0.00139	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—muscle cancer	0.00107	0.00138	CcSEcCtD
Acamprosate—Malaise—Methotrexate—muscle cancer	0.00105	0.00135	CcSEcCtD
Acamprosate—Dizziness—Etoposide—muscle cancer	0.00105	0.00135	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—muscle cancer	0.00104	0.00135	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—muscle cancer	0.00104	0.00135	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—muscle cancer	0.00104	0.00134	CcSEcCtD
Acamprosate—Chills—Doxorubicin—muscle cancer	0.00104	0.00134	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—muscle cancer	0.00102	0.00132	CcSEcCtD
Acamprosate—Cough—Methotrexate—muscle cancer	0.00101	0.00131	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—muscle cancer	0.00101	0.00131	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—muscle cancer	0.00101	0.0013	CcSEcCtD
Acamprosate—Vomiting—Etoposide—muscle cancer	0.00101	0.0013	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—muscle cancer	0.00101	0.0013	CcSEcCtD
Acamprosate—Rash—Etoposide—muscle cancer	0.000999	0.00129	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—muscle cancer	0.000998	0.00129	CcSEcCtD
Acamprosate—Headache—Etoposide—muscle cancer	0.000993	0.00128	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—muscle cancer	0.000992	0.00128	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—muscle cancer	0.00099	0.00128	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—muscle cancer	0.00099	0.00128	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—muscle cancer	0.00099	0.00128	CcSEcCtD
Acamprosate—Tension—Doxorubicin—muscle cancer	0.000988	0.00127	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—muscle cancer	0.000986	0.00127	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000983	0.00127	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—muscle cancer	0.000978	0.00126	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—muscle cancer	0.000978	0.00126	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—muscle cancer	0.000974	0.00125	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—muscle cancer	0.000968	0.00125	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—muscle cancer	0.000957	0.00123	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—muscle cancer	0.000949	0.00122	CcSEcCtD
Acamprosate—Infection—Methotrexate—muscle cancer	0.000943	0.00121	CcSEcCtD
Acamprosate—Nausea—Etoposide—muscle cancer	0.000941	0.00121	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000934	0.0012	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—muscle cancer	0.000931	0.0012	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—muscle cancer	0.000929	0.0012	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—muscle cancer	0.000925	0.00119	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—muscle cancer	0.000922	0.00119	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—muscle cancer	0.000917	0.00118	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—muscle cancer	0.000908	0.00117	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—muscle cancer	0.000905	0.00117	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—muscle cancer	0.000905	0.00117	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—muscle cancer	0.000903	0.00116	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—muscle cancer	0.000901	0.00116	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—muscle cancer	0.00089	0.00115	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—muscle cancer	0.000887	0.00114	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—muscle cancer	0.000885	0.00114	CcSEcCtD
Acamprosate—Cough—Doxorubicin—muscle cancer	0.000879	0.00113	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—muscle cancer	0.000872	0.00112	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—muscle cancer	0.000869	0.00112	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000865	0.00111	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—muscle cancer	0.000858	0.00111	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—muscle cancer	0.000857	0.0011	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—muscle cancer	0.000857	0.0011	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—muscle cancer	0.000857	0.0011	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—muscle cancer	0.000854	0.0011	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—muscle cancer	0.000852	0.0011	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000851	0.0011	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—muscle cancer	0.000847	0.00109	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—muscle cancer	0.000846	0.00109	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—muscle cancer	0.000844	0.00109	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—muscle cancer	0.000838	0.00108	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—muscle cancer	0.000835	0.00108	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—muscle cancer	0.000829	0.00107	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—muscle cancer	0.000825	0.00106	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—muscle cancer	0.000822	0.00106	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000819	0.00106	CcSEcCtD
Acamprosate—Infection—Doxorubicin—muscle cancer	0.000816	0.00105	CcSEcCtD
Acamprosate—Pain—Methotrexate—muscle cancer	0.000812	0.00105	CcSEcCtD
Acamprosate—Shock—Doxorubicin—muscle cancer	0.000808	0.00104	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000805	0.00104	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—muscle cancer	0.000802	0.00103	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—muscle cancer	0.000798	0.00103	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—muscle cancer	0.000794	0.00102	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—muscle cancer	0.000783	0.00101	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—muscle cancer	0.000782	0.00101	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000776	0.001	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—muscle cancer	0.000768	0.000989	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—muscle cancer	0.000754	0.000971	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—muscle cancer	0.00075	0.000967	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—muscle cancer	0.00075	0.000967	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000749	0.000965	CcSEcCtD
Acamprosate—Insomnia—Doxorubicin—muscle cancer	0.000743	0.000958	CcSEcCtD
Acamprosate—Paraesthesia—Doxorubicin—muscle cancer	0.000738	0.000951	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—muscle cancer	0.000733	0.000944	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—muscle cancer	0.000731	0.000941	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—muscle cancer	0.000723	0.000932	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—muscle cancer	0.000714	0.00092	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000709	0.000914	CcSEcCtD
Acamprosate—Pain—Doxorubicin—muscle cancer	0.000703	0.000905	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—muscle cancer	0.000703	0.000905	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—muscle cancer	0.000699	0.000901	CcSEcCtD
Acamprosate—Asthenia—Methotrexate—muscle cancer	0.000681	0.000877	CcSEcCtD
Acamprosate—Feeling abnormal—Doxorubicin—muscle cancer	0.000677	0.000872	CcSEcCtD
Acamprosate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000672	0.000866	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—muscle cancer	0.000671	0.000865	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—muscle cancer	0.000653	0.000841	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—muscle cancer	0.00065	0.000837	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—muscle cancer	0.00065	0.000837	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—muscle cancer	0.000649	0.000837	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—muscle cancer	0.000628	0.000809	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—muscle cancer	0.000605	0.00078	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—muscle cancer	0.000603	0.000777	CcSEcCtD
Acamprosate—Rash—Methotrexate—muscle cancer	0.000598	0.000771	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—muscle cancer	0.000598	0.00077	CcSEcCtD
Acamprosate—Headache—Methotrexate—muscle cancer	0.000594	0.000766	CcSEcCtD
Acamprosate—Asthenia—Doxorubicin—muscle cancer	0.00059	0.00076	CcSEcCtD
Acamprosate—Pruritus—Doxorubicin—muscle cancer	0.000581	0.000749	CcSEcCtD
Acamprosate—Nausea—Methotrexate—muscle cancer	0.000564	0.000726	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—muscle cancer	0.000562	0.000724	CcSEcCtD
Acamprosate—Dizziness—Doxorubicin—muscle cancer	0.000543	0.0007	CcSEcCtD
Acamprosate—Vomiting—Doxorubicin—muscle cancer	0.000522	0.000673	CcSEcCtD
Acamprosate—Rash—Doxorubicin—muscle cancer	0.000518	0.000668	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—muscle cancer	0.000518	0.000667	CcSEcCtD
Acamprosate—Headache—Doxorubicin—muscle cancer	0.000515	0.000663	CcSEcCtD
Acamprosate—Nausea—Doxorubicin—muscle cancer	0.000488	0.000629	CcSEcCtD
